| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 140.4K | $22.44M | - | |
| Other | 52.8K | $8.43M | - | |
| Other | 46.8K | $7.47M | - | |
| Other | 39.6K | $6.33M | -36,937 | |
| Other | 36.8K | $5.89M | -22,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | Cooke Julie59 | Chief Human Resources Officer | Sale+OE | 36,937 | $156.22 | $5,770,235.26 | -18.0% | - | - | |
| Jun 1, 2026 | Onyia Jude54 | Chief Scientific Officer | Sale+OE | 11,000 | $160.25 | $1,762,710.40 | -29.9% | - | - | |
| May 29, 2026 | Delaet Ingrid67 | Chief Regulatory Officer | Sale+OE | 2,261 | $156.71 | $354,321.31 | -12.2% | - | - | |
| May 27, 2026 | Onyia Jude54 | Chief Scientific Officer | Sale+OE | 11,000 | $155.53 | $1,710,865.20 | -29.9% | - | - | |
| May 26, 2026 | Boyer David W.51 | Chief Corp. Affairs Officer | Sell | 3,888 | $156.64 | $609,023.32 | -33.3% | - | - | |
| Dec 16, 2025 | Norwalk Leslie V64 | Director | Sale+OE | 6,190 | $152.78 | $945,701.91 | -31.2% | -12.7% | - | |
| Dec 8, 2025 | Lippoldt Darin60 | Chief Legal Officer | Sale+OE | 4,376 | $159.65 | $698,615.27 | -9.2% | -16.2% | - | |
| Dec 3, 2025 | Lyons Gary A54 | Director | Sale+OE | 15,000 | $152.61 | $2,289,082.50 | -11.1% | -13.7% | - | |
| Nov 28, 2025 | Benevich Eric62 | Chief Commercial Officer | Sale+OE | 5,970 | $151.74 | $905,880.64 | -11.7% | -14.1% | - | |
| Nov 25, 2025 | Morrow George J71 | Director | Sale+OE | 15,000 | $143.37 | $2,150,512.50 | -68.0% | -10.5% | - |